Autologous Chemotaxis as a Mechanism of Tumor Cell Homing to Lymphatics via Interstitial Flow and Autocrine CCR7 Signaling

Cancer Cell

Volumn 11, Issue 6, 2007, Pages 526-538

  Shields, Jacqueline D ^a   Fleury, Mark E ^a   Yong, Carolyn ^a   Tomei, Alice A ^a   Randolph, Gwendalyn J ^b   Swartz, Melody A ^a  

^a EPFL   (Switzerland)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CELLBIO

Indexed keywords

CHEMOKINE RECEPTOR CCR7; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ARTICLE; AUTOCRINE EFFECT; CELL MIGRATION; CELL POLARITY; CHEMOTAXIS; COMPUTER SIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPH FLOW; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 34249774277     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.04.020     Document Type: Article

References (53)

1. Arya M., Patel H.R., McGurk C., Tatoud R., Klocker H., Masters J., and Williamson M. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. J. Exp. Ther. Oncol. 4 (2004) 291-303
2. Ashe H.L., and Briscoe J. The interpretation of morphogen gradients. Development 133 (2006) 385-394
3. Cabioglu N., Yazici M.S., Arun B., Broglio K.R., Hortobagyi G.N., Price J.E., and Sahin A. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin. Cancer Res. 11 (2005) 5686-5693
4. Cailleau R., Olive M., and Cruciger Q.V. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14 (1978) 911-915
5. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
6. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2 (2002) 563-572
7. Charest P.G., and Firtel R.A. Big roles for small GTPases in the control of directed cell movement. Biochem. J. 401 (2007) 377-390
8. Chary S.R., and Jain R.K. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc. Natl. Acad. Sci. USA 86 (1989) 5385-5389
9. Clarijs R., Schalkwijk L., Ruiter D.J., and de Waal R.M. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1422-1428
10. Dafni H., Israely T., Bhujwalla Z.M., Benjamin L.E., and Neeman M. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: Magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. Cancer Res. 62 (2002) 6731-6739
11. Darash-Yahana M., Pikarsky E., Abramovitch R., Zeira E., Pal B., Karplus R., Beider K., Avniel S., Kasem S., Galun E., and Peled A. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J. 18 (2004) 1240-1242
12. Debes G.F., Arnold C.N., Young A.J., Krautwald S., Lipp M., Hay J.B., and Butcher E.C. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 6 (2005) 889-894
13. Ding Y., Shimada Y., Maeda M., Kawabe A., Kaganoi J., Komoto I., Hashimoto Y., Miyake M., Hashida H., and Imamura M. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin. Cancer Res. 9 (2003) 3406-3412
14. Engel L.W., Young N.A., Tralka T.S., Lippman M.E., O'Brien S.J., and Joyce M.J. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 38 (1978) 3352-3364
15. Fleury M.E., Boardman K.C., and Swartz M.A. Autologous morphogen gradients by subtle interstitial flow and matrix interactions. Biophys. J. 91 (2006) 113-121
16. Forster R., Schubel A., Breitfeld D., Kremmer E., Renner-Muller I., Wolf E., and Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99 (1999) 23-33
17. Fukata M., Nakagawa M., and Kaibuchi K. Roles of Rho-family GTPases in cell polarisation and directional migration. Curr. Opin. Cell Biol. 15 (2003) 590-597
18. Griffith L., and Swartz M. Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. (2006) in press
19. Gunn M.D., Tangemann K., Tam C., Cyster J.G., Rosen S.D., and Williams L.T. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95 (1998) 258-263
20. Gunther K., Leier J., Henning G., Dimmler A., Weissbach R., Hohenberger W., and Forster R. Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int. J. Cancer 116 (2005) 726-733
21. He Y., Rajantie I., Pajusola K., Jeltsch M., Holopainen T., Yla-Herttuala S., Harding T., Jooss K., Takahashi T., and Alitalo K. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 65 (2005) 4739-4746
22. Helm C.L., Fleury M.E., Zisch A.H., Boschetti F., and Swartz M.A. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc. Natl. Acad. Sci. USA 102 (2005) 15779-15784
23. Heresi G.A., Wang J., Taichman R., Chirinos J.A., Regalado J.J., Lichtstein D.M., and Rosenblatt J.D. Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: Report of a case, review of the literature, and analysis of chemokine receptor expression. Urol. Oncol. 23 (2005) 261-267
24. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 9 (2003) 685-693
25. Jain R.K. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307 (2005) 58-62
26. Janetopoulos C., Ma L., Devreotes P.N., and Iglesias P.A. Chemoattractant-induced phosphatidylinositol 3,4,5-trisphosphate accumulation is spatially amplified and adapts, independent of the actin cytoskeleton. Proc. Natl. Acad. Sci. USA 101 (2004) 8951-8956
27. Kleinman H.K., and Martin G.R. Matrigel: Basement membrane matrix with biological activity. Semin. Cancer Biol. 15 (2005) 378-386
28. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., Banerji S., Huarte J., Montesano R., Jackson D.G., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20 (2001) 672-682
29. Mashino K., Sadanaga N., Yamaguchi H., Tanaka F., Ohta M., Shibuta K., Inoue H., and Mori M. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 62 (2002) 2937-2941
30. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
31. Nathanson S.D. Insights into the mechanisms of lymph node metastasis. Cancer 98 (2003) 413-423
32. Ng C.P., Hinz B., and Swartz M.A. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J. Cell Sci. 118 (2005) 4731-4739
33. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., Blankenstein T., Henning G., and Forster R. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 (2004) 279-288
34. Patel D.D., Koopmann W., Imai T., Whichard L.P., Yoshie O., and Krangel M.S. Chemokines have diverse abilities to form solid phase gradients. Clin. Immunol. 99 (2001) 43-52
35. Podgrabinska S., Braun P., Velasco P., Kloos B., Pepper M.S., and Skobe M. Molecular characterization of lymphatic endothelial cells. Proc. Natl. Acad. Sci. USA 99 (2002) 16069-16074
36. Randolph G.J., Angeli V., and Swartz M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5 (2005) 617-628
37. Rae J.M., Ramus S.J., Waltham M., Armes J.E., Campbell I.G., Clarke R., Barndt R.J., Johnson M.D., and Thompson E.W. Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin. Exp. Metastasis 21 (2004) 543-552
38. Rae J.M., Creighton C.J., Meck J.M., Haddad B.R., and Johnson M.D. MDA-MB-435 cells are derived from M14 melanoma cells-A loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treat (2006) 10.1007/s10549-006-9392-8 Published online September 27
39. Servant G., Weiner O.D., Herzmark P., Balla T., Sedat J.W., and Bourne H.R. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287 (2000) 1037-1040
40. Shields J.D., Emmett M.S., Dunn D.B., Joory K.D., Sage L.M., Rigby H., Mortimer P.S., Orlando A., Levick J.R., and Bates D.O. Chemokine-mediated migration of melanoma cells towards lymphatics-A mechanism contributing to metastasis. Oncogene 26 (2007) 2997-3005 10.1038/sj.onc.1210114 Published online November 27, 2006
41. Sipos B., Kojima M., Tiemann K., Klapper W., Kruse M.L., Kalthoff H., Schniewind B., Tepel J., Weich H., Kerjaschki D., and Kloppel G. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J. Pathol. 207 (2005) 301-312
42. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., and Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7 (2001) 192-198
43. Soule H.D., Maloney T.M., Wolman S.R., Peterson Jr. W.D., Brenz R., McGrath C.M., Russo J., Pauley R.J., Jones R.F., and Brooks S.C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50 (1990) 6075-6086
44. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., Jackson D.G., Nishikawa S., Kubo H., and Achen M.G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7 (2001) 186-191
45. Takanami I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: Correlation with lymph node metastasis. Int. J. Cancer 105 (2003) 186-189
46. Takeuchi H., Fujimoto A., Tanaka M., Yamano T., Hsueh E., and Hoon D.S. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin. Cancer Res. 10 (2004) 2351-2358
47. Uchimura K., Morimoto-Tomita M., Bistrup A., Li J., Lyon M., Gallagher J., Werb Z., and Rosen S.D. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: Effects on VEGF, FGF-1, and SDF-1. BMC Biochem. 7 (2006) 2
48. Wang J., Zhang X., Thomas S.M., Grandis J.R., Wells A., Chen Z.G., and Ferris R.L. Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene 24 (2005) 5897-5904
49. Wiley H.E., Gonzalez E.B., Maki W., Wu M.T., and Hwang S.T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J. Natl. Cancer Inst. 93 (2001) 1638-1643
50. Williams C.S., Leek R.D., Robson A.M., Banerji S., Prevo R., Harris A.L., and Jackson D.G. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J. Pathol. 200 (2003) 195-206
51. Wong S.Y., Haack H., Crowley D., Barry M., Bronson R.T., and Hynes R.O. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res. 65 (2005) 9789-9798
52. Yucel G., and Small S. Morphogens: Precise outputs from a variable gradient. Curr. Biol. 16 (2006) R29-R31
53. Zigmond S.H. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J. Cell Biol. 75 (1977) 606-616